New Results
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication
View ORCID ProfileIart Luca Shytaj, Mohamed Fares, Bojana Lucic, Lara Gallucci, Mahmoud M. Tolba, Liv Zimmermann, Ahmed Taha Ayoub, Mirko Cortese, Christopher J. Neufeldt, Vibor Laketa, Petr Chlanda, Oliver T. Fackler, Steeve Boulant, Ralf Bartenschlager, Megan Stanifer, Andrea Savarino, Marina Lusic
doi: https://doi.org/10.1101/2021.03.09.434219
Iart Luca Shytaj
1Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany
2Federal University of São Paulo, Infectious Diseases Department, São Paulo, Brazil
Mohamed Fares
3Department of Hydrobiology, Veterinary Research Division, National Research Centre, Cairo, Egypt
Bojana Lucic
1Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany
4German Center for Infection Research (DZIF), Heidelberg, Germany
Lara Gallucci
1Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany
Mahmoud M. Tolba
5Pharmaceutical Division, Ministry of Health and Population, Faiyum, Egypt
Liv Zimmermann
6Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany
7Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany
Ahmed Taha Ayoub
8Biomolecular Simulation Center, Department of Pharmaceutical Chemistry, Heliopolis University, Cairo, Egypt
Mirko Cortese
9Department of Infectious Diseases, Molecular Virology, CIID, Heidelberg University, Heidelberg, Germany
Christopher J. Neufeldt
9Department of Infectious Diseases, Molecular Virology, CIID, Heidelberg University, Heidelberg, Germany
Vibor Laketa
4German Center for Infection Research (DZIF), Heidelberg, Germany
6Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany
Petr Chlanda
6Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany
7Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany
Oliver T. Fackler
1Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany
4German Center for Infection Research (DZIF), Heidelberg, Germany
Steeve Boulant
6Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany
Ralf Bartenschlager
4German Center for Infection Research (DZIF), Heidelberg, Germany
9Department of Infectious Diseases, Molecular Virology, CIID, Heidelberg University, Heidelberg, Germany
Megan Stanifer
9Department of Infectious Diseases, Molecular Virology, CIID, Heidelberg University, Heidelberg, Germany
Andrea Savarino
10Department of Infectious and Immune-Mediated Diseases, Italian Institute of Health, Rome, Italy
Marina Lusic
1Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany
4German Center for Infection Research (DZIF), Heidelberg, Germany
Posted March 09, 2021.
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication
Iart Luca Shytaj, Mohamed Fares, Bojana Lucic, Lara Gallucci, Mahmoud M. Tolba, Liv Zimmermann, Ahmed Taha Ayoub, Mirko Cortese, Christopher J. Neufeldt, Vibor Laketa, Petr Chlanda, Oliver T. Fackler, Steeve Boulant, Ralf Bartenschlager, Megan Stanifer, Andrea Savarino, Marina Lusic
bioRxiv 2021.03.09.434219; doi: https://doi.org/10.1101/2021.03.09.434219
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication
Iart Luca Shytaj, Mohamed Fares, Bojana Lucic, Lara Gallucci, Mahmoud M. Tolba, Liv Zimmermann, Ahmed Taha Ayoub, Mirko Cortese, Christopher J. Neufeldt, Vibor Laketa, Petr Chlanda, Oliver T. Fackler, Steeve Boulant, Ralf Bartenschlager, Megan Stanifer, Andrea Savarino, Marina Lusic
bioRxiv 2021.03.09.434219; doi: https://doi.org/10.1101/2021.03.09.434219
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)